Nalan Alan Selçuk

The role of 68Ga-FAPi PET/CT in Staging and Restaging of Breast Cancer Subtypes with Limited 18F-FDG Uptake

Gamze Beydağı, Nalan Alan Selçuk, Kaan Akçay, Ayşegül Görmez et autres

Objectives: F-FDG PET/CT has low sensitivity. Methods: ) of primary tumors and metastases were recorded for both tracers and compared using paired t-tests. Results: in primary lesions and metastases (p<0.05). Conclusion: F-FDG-avid subtypes-supporting its potential role in clinical decision-making and treatment planning.

tr (code pays fourni par la source)

Dose–Response and survival analysis after transarterial radioembolization for intrahepatic cholangiocarcinoma: A multicenter multicompartment dosimetry study

Çiğdem Soydal, Tunc Ones, Murat Fani Bozkurt, Emine Göknur Işık et autres

AIM: We aimed to report real-world outcomes of transarterial radioembolization (TARE) in patients with intrahepatic cholangiocarcinoma (ICC), focusing on different microsphere types and posttreatment dosimetric approaches in relation to dose-response and survival analyses. MATERIALS AND METHODS: This multicenter retrospective single-arm cohort study …

tr (code pays fourni par la source)

Tumor absorbed dose and outcomes after Y-90 glass radioembolization for colorectal liver metastases: does dose escalation improve survival in real-world practice?

Osman Melih Topçuoğlu, Betul Uzunoglu, Tolga Orhan, Ismail Necim Yucel et autres

PURPOSE: To assess the dose-response and dose-survival outcomes of yttrium-90 (Y90) transarterial radioembolization (TARE) using Therasphere microspheres in patients with colorectal cancer liver metastases (CRCLM). MATERIAL AND METHODS: Between May 2014 and December 2024, patients with chemorefractory CRCLM who underwent Y90 TARE …

tr (code pays fourni par la source)

[225AC]AC-PSMA AND OTHER TARGETED ALPHA RADIONUCLIDE THERAPIES IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER: RADIONUCLIDES, RADIOPHARMACEUTICALS AND INITIAL CLINICAL FINDINGS

Nalan Alan Selçuk, LEVENT KABASAKAL

INTEGRATION OF [68GA]GA PSMA PET/CT FOR THE SELECTION OF PATIENTS ELIGIBLE FOR ACTIVE SURVEILLANCE

LEVENT KABASAKAL, Nalan Alan Selçuk

Istanbul PSMA PET/CT criteria (IPPC): an imaging-based approach to patient selection for active surveillance

Levent Kabasakal, Kaan Akçay, Nalan Alan Selçuk, Gamze Beydağı et autres

tr, kh, ag (code pays fourni par la source)

The role of [⁶⁸Ga]Ga-FAP-2286 PET/CT in the evaluation of treatment response in gastrointestinal system malignancies

Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay, Ayşegül Görmez et autres

tr (code pays fourni par la source)

Benign bone lesions mimicking metastasis on 68Ga-FAPI PET/CT

Mehmet Tarık Tatoğlu, Nalan Alan Selçuk, Kendal Erincik

Keywords n/a Publication History Received: 28 March 2025 Accepted: 08 April 2025 Article published online: 06 August 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

tr (code pays fourni par la source)

Cancer Integrin Imaging with [68Ga]Ga-Trivehexin PET/CT for a Patient with Breast Cancer and Neuroendocrine Neoplasm: A Case of Both (18F)FDG PET/CT and [68Ga]Ga-DOTATATE Positive but Integrin avβ6 Negative Lesion on [68Ga]Ga-Trivehexin PET

Gamze Beydağı, Nalan Alan Selçuk, Kaan Akçay, Onur Yaprak et autres

Cancer Integrin Imaging with [68Ga]Ga-Trivehexin PET/CT for a Patient with Breast Cancer and Neuroendocrine Neoplasm: A Case of Both (18F)FDG PET/CT and [68Ga]Ga-DOTATATE Positive but Integrin avβ6 Negative Lesion on [68Ga]Ga-Trivehexin PET - Molecular Imaging and Radionuclide Therapy

tr (code pays fourni par la source)

Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival

Çiğdem Soydal, Mine SOYLU ARAZ, Burak Furkan Demir, Trevor Jones et autres

In this multicenter retrospective study, we aimed to analyze the dose–response and survival relationships and estimate the tumor absorbed radiation dose required to achieve response in colorectal cancer liver metastases treated with 90Y glass microspheres. Methods: Patients with metastatic colorectal cancer treated …

tr (code pays fourni par la source)

The Role of [68Ga]Ga FAPi PET/CT in Staging and Restaging in Breast Cancer with Low FDG Uptake

Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay, Ayşegül Görmez et autres

tr (code pays fourni par la source)

Impact of 68Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18F-FDG PET/CT Findings

Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay, Emre E. Demirci et autres

Impact of 68 Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18 F-FDG PET/CT Findings Negatif veya Şüpheli 18 F-FDG PET/BT Bulguları olan Digestif Sistem Tümörlü Olguların Evrelenmesi ve Yeniden Evrelenmesinde 68 Ga-FAPi PET/BT'nin rolü

tr, us (code pays fourni par la source)